LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 69.32 | 771.67 | 5985 | 10212 | 0.5861 | 0.7328 | MN20160304_L01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 71.54 | 771.67 | 5660 | 10532 | 0.5374 | 0.6963 | MN20160304_L01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 71.54 | 771.67 | 6137 | 10532 | 0.5827 | 0.7331 | MN20160304_L01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 73.76 | 771.67 | 5855 | 10851 | 0.5395 | 0.7012 | MN20160304_L01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 73.76 | 771.67 | 6281 | 10851 | 0.5788 | 0.7329 | MN20160304_L01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 76.02 | 771.67 | 6012 | 11106 | 0.5413 | 0.7051 | MN20160304_L01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 76.02 | 771.67 | 6414 | 11106 | 0.5775 | 0.7340 | MN20160304_L01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 78.25 | 771.67 | 6179 | 11367 | 0.5436 | 0.7093 | MN20160304_L01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 78.25 | 771.67 | 6609 | 11367 | 0.5814 | 0.7392 | MN20160304_L01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 80.48 | 771.67 | 6330 | 11685 | 0.5417 | 0.7105 | MN20160304_L01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 80.48 | 771.67 | 6742 | 11685 | 0.5770 | 0.7382 | MN20160304_L01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 82.69 | 771.67 | 6507 | 11974 | 0.5434 | 0.7143 | MN20160304_L01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 82.69 | 771.67 | 6838 | 11974 | 0.5711 | 0.7359 | MN20160304_L01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 84.92 | 771.67 | 6594 | 12266 | 0.5376 | 0.7119 | MN20160304_L01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 84.92 | 771.67 | 6887 | 12266 | 0.5614 | 0.7306 | MN20160304_L01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 87.14 | 771.67 | 6808 | 12592 | 0.5406 | 0.7168 | MN20160304_L01 | D10 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 87.14 | 771.67 | 7025 | 12592 | 0.5579 | 0.7303 | MN20160304_L01 | M06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 2.49 | 771.67 | 836 | 867 | 0.9634 | 0.6048 | MN20160304_L01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 2.49 | 771.67 | 713 | 867 | 0.8217 | -0.3732 | MN20160304_L01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 4.71 | 771.67 | 966 | 956 | 1.0101 | 1.0657 | MN20160304_L01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 4.71 | 771.67 | 834 | 956 | 0.8720 | 0.2852 | MN20160304_L01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 6.94 | 771.67 | 1044 | 1045 | 0.9989 | 0.9951 | MN20160304_L01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 6.94 | 771.67 | 919 | 1045 | 0.8793 | 0.4907 | MN20160304_L01 | G15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 9.16 | 771.67 | 1149 | 1138 | 1.0092 | 1.0330 | MN20160304_L01 | E22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 9.16 | 771.67 | 991 | 1138 | 0.8704 | 0.5618 | MN20160304_L01 | G15 |